Mianserin Kept Worms Young Longer: What the Scripps Study Found

Facebook ↗WhatsApp ↗
An Antidepressant Extended Young Adulthood in Worms
Peter Griffin/public domain

In 2015 scientists at The Scripps Research Institute in California reported that an antidepressant called mianserin made laboratory roundworms stay physiologically young for longer, and as a result live longer. The effect came from stretching the worms’ young adult phase rather than adding extra years of old age at the end. The researchers were quick to stress the limits: this was done in tiny worms, the drug is not an anti-ageing pill, and nobody should take it hoping to stay twenty-something.

The study, led by Michael Petrascheck with first author Sunitha Rangaraju, was published in the journal eLife. Its most lasting contribution may not be the drug at all, but a new way of measuring ageing that the team called “transcriptional drift”. Here is what they did, what they found, and what it does and does not mean for people.

The short answer: what the study found

  • Roundworms (Caenorhabditis elegans) given mianserin lived longer, building on the same lab’s 2007 finding that the drug extends worm lifespan by around 30 to 40 percent.
  • The drug worked by delaying age-related changes during young adulthood. Treated 10-day-old worms still looked, at the level of gene activity, like 3-day-old worms.
  • There was a time window. Once the worms reached about 12 days of age, continued treatment added nothing further.
  • As worms aged, groups of genes that normally work together drifted out of step. The team named this transcriptional drift and found signs of the same pattern in mice and in human brain samples.
  • Mianserin slowed this drift by blocking serotonin signalling, and the death curve of treated worms shifted later by roughly a week.

How the experiment worked

C. elegans is a transparent worm about a millimetre long, and it is one of biology’s favourite model organisms. It reaches adulthood about three days after hatching, normally lives for only two to three weeks, and shares many basic genetic pathways with humans. That makes it ideal for ageing research: you can follow thousands of animals from youth to death in a month.

The team raised large groups of worms and treated them either with plain water or with mianserin. They then measured which genes were switched on, and how strongly, at different ages. Gene activity in young adult worms served as the baseline. Any changes from that baseline, as the animals got older, became a molecular record of ageing.

Earlier work had shown that mianserin made the worms live longer, but not how. Comparing gene activity over time in treated and untreated worms was meant to answer that question.

Transcriptional drift: a new way to measure ageing

The researchers expected genes to change with age. What surprised them was the pattern. Genes that belong to the same biological job, and normally rise and fall together, started moving in opposite directions. Within a single functional group, some genes became more active while others became less active. Coordination was breaking down.

The team called this loss of coordination transcriptional drift. To see whether it was just a quirk of worms, they looked at existing data from mice and from post-mortem brain tissue of 32 people aged 26 to 106. The same kind of drift appeared there too, which suggests it may be a general feature of ageing in animals.

Why does this matter? Most ageing studies rely on counting deaths. That works for old animals, but in young adults deaths are rare, so it is hard to see early changes. Rangaraju explained the value plainly: transcriptional drift “can be used as a new metric for measuring age-associated changes that start in young adulthood.” A measure like this could help researchers study conditions where ageing seems to begin unusually early, such as the rare genetic disorder Hutchinson-Gilford progeria syndrome.

What mianserin did, and when

Using drift as their yardstick, the scientists found that mianserin held back the molecular changes of ageing, but only during a specific stage of life. By day 10, treated worms still had gene activity typical of 3-day-olds, meaning they were about seven days younger in biological terms. After about day 12, the window closed: keeping the worms on the drug for the rest of their lives gave no extra benefit.

The death data matched. Instead of living the same life with a longer frail tail, treated worms had a mortality curve that was shifted later, in parallel, by about seven to eight days. In other words, the drug lengthened the young, healthy part of life and pushed everything after it back.

The mechanism involves serotonin. Mianserin blocks several serotonin receptors, and in the worms this interference with serotonin signals appears to have slowed both the drift and the later degenerative changes that lead to death.

What this means for people (and what it does not)

Petrascheck was clear that the result should not be read as a human anti-ageing treatment. As he put it: “We may have done this in worms, but there are millions of years of evolution between worms and humans.” A few practical points follow.

  • Mianserin is a real prescription antidepressant. It is a tetracyclic drug used mainly in Europe and some other countries for depression and, at low doses, for sleep problems. It is not approved in the United States.
  • It has side effects. Drowsiness, dry mouth, constipation, dizziness and weight gain are among those listed, and stopping suddenly can cause withdrawal symptoms. It is not something to take for any off-label reason.
  • Worm results often fail to carry over. Many compounds that lengthen worm or fly lifespan have small or no effects in mammals, and the scientists themselves said any effect in mammals could be much weaker.
  • The next steps were in mice. The team planned to test whether the effect exists in mice, whether it has side effects, whether different organs respond differently, and whether environment changes the outcome.

If you are interested in healthy ageing, or you take or are considering an antidepressant, talk to a doctor. Do not start, stop or change any medicine on the basis of animal studies.

Common myths about this research

“Scientists found a pill that keeps you young”

No. They found that one drug delayed molecular ageing in worms during a narrow window of early adulthood. That is a long way from any human treatment.

“It was a total accident”

Headlines called it an accidental discovery, but the 2015 paper was a deliberate follow-up. The lifespan effect had been found in a 2007 screen of existing drugs, and this study set out to explain it. What was unexpected was the transcriptional drift pattern the team found along the way.

“Antidepressants slow ageing”

The study involved one drug acting on serotonin signalling in one species. It says nothing about antidepressants in general, and nothing about their effect on human lifespan.

Why the study still matters

Even without a human application, the work did two useful things. It showed that lifespan can be extended by lengthening young adulthood rather than by stretching out old age, a pattern many people would find more appealing. And it gave ageing researchers a molecular clock, transcriptional drift, that can detect age-related changes long before animals start dying.

Whether a longer youth would be as desirable for humans as it sounds, and how it would affect families, careers and societies, is a question for another day. For now, it remains a striking result in worms and a promising tool for science.

Sources: Rangaraju S. et al., “Suppression of transcriptional drift extends lifespan by postponing the onset of mortality”, eLife 2015, DOI: 10.7554/eLife.08833; Medical Xpress / The Scripps Research Institute, 2 December 2015; Wikipedia: Mianserin. Image: Peter Griffin, public domain.

Related:

COMMENTS